Just one of the same old true believers hiding behind another new alias. Now that's conviction, indeed!
Hey gang, does anyone know if Barnhizer is going to assign, if granted, his N-Assay patent interest to NNLX?
"Inventions By Company Officers
If an employee inventor is an officer of the employer, ownership is more likely to tip towards the company than the employee. Officers of a company have a special duty (known as a “fiduciary duty”) to the company. At least one state court has found that the officer of a corporation has a fiduciary duty to assign his employee-created invention to his employer."
"Who Owns Patent Rights? Employer or Inventor?"
"Based on the test results page, looks pretty impressive to me. Efficient better yet."
joev, most of those results were posted years ago. I know they look impressive but why didn't any of these results drive sales for the two products as Barnhizer thought they would?
Why is the one with the lowest times for several target bacteria not even listed as a product any longer?
Just throwing out a couple substantive items for you to mull over rather than getting further caught up in the briar patch that is who is behind which posting aliases and what happened to the former CEO.
"I don't see anything about the BNF being for sale, never have."
Another case of selective memory from one of the true believers? Don't you recall this notice Barnhizer put on the BNF products page back in 2012 that remained there for about two years (or longer) before the whole BNF product page was pulled down:
"Recent BNF quick change kit discoveries and product performance improvements have dramatically reduced detection and identification times. Product ordering is temporarily suspended as we optimize these product developments and design changes."
Of course, zagy, suspending something means to stop doing something that was being done up until that point (i.e., offering these BNF kits for purchase)-- or do you think the CEO playing fast and loose with what had been going on back then?
"someone please tell me this is the same guy"
OK, joev, he's the same guy. Really, there is only one person behind all aliases on this board except yours.
"Why don't you call the company and ASK. I did,..."
Thanks, wiz, for the info. I knew someone from the inner sanctum would get some sort of explanation from Barnhizer lickety-split.
"Dr. Faro is no longer on their Science Advisory Board BECAUSE the N-Assay paper is being submitted to a journal for review and publication AND the journal has strict guidelines regarding any potential conflicts of interest, as in serving on a company's Science Advisory Board while you submit a paper."
That's actually a low bar to clear for disclosure of potential conflicts of interest. So will Faro the elder now be able to declare no potential conflicts of interest need be disclosed? Was he also required to sell any NNLX stock he may have been holding? Top journals such as Lancet and JAMA require disclosure of relationships with, and interests in, related commercial entities going back a number of years that could be signs of conflicts of interest. Resigning from an SAB at the time of submission for the reason you posted just seems to be playing games if that is indeed the extent of what this journal requires.
"As for the patent attorney leaving, I was told NNLX had reached the point where patents issued and in process no longer required her services and she then resigned from the Science Advisory Board. Science Advisory Board members coming and going happens in any company."
It's somewhat common for companies to recognize the service of top leaders when they depart under amicable circumstances. Not seeing Barnhizer post such a public nod to these fine folks when they resigned, IMO, unnecessarily leaves the public wondering and speculating; no news can indicate messiness when it comes to these types of changes. It's a good thing, though, Barnhizer has posters like you to rely on to get his explanations out after the fact.
...at least according to the company website this AM. Absent any other explanation from the company, I wouldn't be surprised if N-Assay ownership issues are behind this most recent departure from the company's SAB, along with Acker Wood's earlier in the year.
"Erick, He's not using innuendo,, by use of the word " skimming" relative to taking money, he is actually accusing the CEO of an illegal act. "
You're wrong again but that's no surprise. Taking that word out of context to make some sort of heavy-handed accusation of impropriety on the part of the poster is lame and only makes you look desperate.
"I wish you people would get this done properly," Judge Lanzo told Barnhizer."
Classic. Is this really what the judge said to His Royal Heightness? If so, just another way in which there seems to be overlap in conduct between the personal and professional. Does anyone know if the dog-ate-my-permit defense was invoked?
Or maybe if this declaration was offered to the judge the verdict would have been NG:
Under personnel and financial resource constraints previously addressed, what this homeowner does should not be viewed as one would view what major home builders accomplish for timelines.
Can anyone confirm who owns N-Assay? If it's not NanoLogix, what kind of licensing deal does NNLX have with the owners? It doesn't look like the patent app assigns N-Assay to NNLX as was done with some other dx-related inventions. Furthermore, the "N-Assay" trademark is registered/owned by Barnhizer not NanoLogix. NanoLogix did, however, register "It Kicks Assay" last year but that was abandoned earlier this year.
From a 2014 company PR:
"The technology referenced in the poster is NanoLogix’s patent-pending “N-Assay” Multiwell Microplate, a unique ELISA assay that ongoing research to date has shown enables detection and identification of bacteria and yeasts rapidly and with greater sensitivity than any other diagnostic currently available."
"The results, in a few words, are: very positive, huge, phenomenal, great, unprecedented , to say the least...The N-Assay is a non-subjective, computer-readable ELISA diagnostic. The BNF is not, period. We will focus upon what is the best technology, which is the N-Assay."
In fewer words, classic Barnhizer hype. Only (more) time will tell whether this time the results that get published will finally match the big talk and lead to a commercially successful, differentiated dx product.
"According to the Singapore HSA, the registration of a sterile Class A device doesn't take very long. Things must take longer for the distributor to jump thru the hoops."
Even if Barnhizer described them as "such an accomplished business group", it looks like IVD Tech is a business that only incorporated a couple weeks prior to signing that agreement with NNLX back in Feb 2014. Was the matter of getting licenses ever mentioned by Barnhizer in an update over the past year+ as a very lengthy process that needed to be carefully navigated before sales could begin?
How do the bootlickers reconcile the current explanation about SIngapore having a tough licensing bureaucracy with this statement in the original PR:
"Engagement has already started with potential channel partners and end users in Singapore, Japan, China and other countries. "
Taking more than 18 months to get those requisite licenses to move NNLX dishes into /through Singapore is a joke. And I have a difficult time buying the line that it took so long because of the Singapore government. Singapore is a very business-friendly country. In fact, the World Bank ranked it tops in the world in its most recent annual survey ("Doing Business 2015") of how countries stack-up business-wise. This looks more like another dog-ate-my-homework excuse for poor execution by a dubious foreign partner.
Does anyone recall the AMGKWT dry hole? So has the "accomplished business group" known as IVD Tech even accomplished a website?
"They also got lathered up over open house Industry Day."
The last PR-worthy news NNLX generated was indeed a full year ago. The chatter was about N-Assay to detect ebola. However, NNLX needed someone, according to the PR, to do the heavy lifting research-wise to configure that test to detect nasty viruses such as ebola and bring it to market. After a year with no further PRs on this (or anything), it looks like no one thought the N-Assay was worth the effort or that any company with the requisite capabilities and cash agreed w/the assertion that it was "a matter of national security and an emergency priority" to help the Farnhizers with this.
"The Company (Orasure) announced that the Biomedical Advanced Research Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) has exercised an option to provide $7.2 million in additional funding for the Company's OraQuick® Ebola Rapid Antigen Test..."
Remember when the uber-faithful got all lathered-up over the discovery that NNLX looked to have applied for a BARDA grant related to anthrax? Of course that turned out to be just another in a still-growing number of dry holes this company has drilled.
Now the friends&family gang are in a prolonged state of drooling until the Farnhizer gang finally finish the N-Assay lab tests (were they really held-up by a couple so-called bad anti-body batches or is something else the problem?) and actually get some data published that breaks the string of research papers about NNLX dx tech over the years that have been met with a big, fat yawn by the market. Yet any peer-reviewed paper likely won't be released until well after the new year and with Barnhizer still sitting on multiple quarters worth of financials it just looks like more of the same ol', same ol'.
Here's an excerpt of how one well-regarded poster, nyckenm, described the event. Note the comments on orders and marketing. Anybody want to post some revisionist history to his account? It was sure lapped it up back then.
"...as a surgeon who often deals with limb-threatening infections, I felt that I would have an apporpriate[sic] background to speak with the scientists and further analyze the technology. I was very happy to have attended since the meeting confirmed my decision to hold all of my shares and continue to add to my position.
1. NNLX has standing orders of 1000s of BNP kits per week. Customers are REPEAT customers, which means they like the kits. Customers include Proctor and Gamble, 3M, Batelle and Becton-Dickinson. These are all giant companies.
2. All measures on the proxy votes passed. This offers protection against a hostile takeover. BB stated that the company would listen to takeovers at the proper price.
3. Clean room is almost finished. It was built at the fraction of the cost that other contractors were willing to build. The total cost is $43k and this final bill we be around $100k. NNLX has the cash to finish the building. They are waiting on NB to deliver the equipment and will be ready to accept and install when NB gives them a date.
4. BB and NNLX board has not diluted the stock. I believe BB said there was 101 million shares at this time. He specifically said that he and the board have significant shares in NNLX and as a result, he did not want to dilute in order to build the clean room. He is looking out for the best interest of the shareholders because he is a large one too.
5. A marketing firm and startegy[sic] is in place, but he would not reveal the details.
8. BNP has been the focus since it is easy to use and cheap, but NNLX has great hope for BNC in the future. Batelle feels BNC may displace PCR in some settings.
9. Confirmation the the EPA has a 2 year LOI with NNLX to further develop BNF."
" I see nothing to indicate Commish is being compensated for bashing NNLX...he only consistent agenda I see is his effort to show that NNLX has not demonstrated itself to be a major player in the field, and that suggestions that NNLX may the "only" company with potential promise to solve some of the detection problems are overblown, because others are working in the same basic space NNLX is, and some are doing it much more successfully."
Indeed. Anyone that thinks the reason this stinky pink stock is in the dumps is because of anything critical posted on this message board is delusional. NNLX does not exist in a vacuum. The meager and painfully slow progress it makes in fits and starts cannot support the value it earlier held as even a long-term proposition for the most patient of competent investors.
Barnhizer continues to appear to be unable to grasp and manage the numerous challenges involved in successfully bringing a diagnostic product to market in a timely manner. Either he is a slower learner that I earlier thought or communicates overly optimistic forecasts for reasons that should be obvious to even the most ardent in his fan club. That is the fundamental problem, not anything critical that gets posted here.
How else do you explain company statements like the one that in April 2013 forecast the beginning of marketing the N-Assay that same summer when "refining" the product continues two years hence? And how about the BNF mystery? Once listed as a product for sale but then shown for a couple years as "temporarily" unavailable while the product was being "optimized", it's now not even mentioned as a company diagnostic product.
"I called NanoLogix last week and was told that there have been two bad batches of antibodies delivered in July and August and they didn't provide the results they'd seen with the earlier batch in June. When I asked about updating in an email I was told that it would be seen as making excuses for something that was beyond the company's control..."
Let a toady do the dirty work of spreading the bad news for him. Nice. Is the Farnhizer cabal sourcing antibodies via Craig's List?
So amateur hour continues with little/no apparent interest by a reputable and competent commercial entity to help get this product properly validated in a timely manner even with the alleged preliminary data that has been trumpeted. What's the company's motto? Tomorrow's results next year?
"Two record setting sales days is what one update was about."
Barnhizer has once again showed how a typical stinky pink stock company rolls. He is simply cherry-picking the data he feeds to the uber-bulls to keep them from whining to him too much. In fact, I wouldn't be surprised if he released this tidbit exactly because he has been getting more and more panicky calls from the friends&family gang.
Of course serious investors wouldn't give him a pass on this, let alone get excited enough to now buy NNLX stock. As keembo observed, highlighting one-day sales data without sharing the type of quarterly or monthly numbers real public companies regularly and predictably release for context is a joke, making it, IMO, pretty clear what Barnhizer's motivation for doing this was.